User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions

→‎Lymphoma: + 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov[1st seen in 1], a 2005 comparative study, published in w:FEBS Letters
(→‎Brain cancer and cannabis: + 'Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma' at search.proquest.com, a 2021 study published in w:Cell (journal)... + <ref group="1st seen in" name="RXLeafGlioma2021">)
(→‎Lymphoma: + 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov[1st seen in 1], a 2005 comparative study, published in w:FEBS Letters)
Line 389: Line 389:
== Lymphoma ==
== Lymphoma ==
[[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia)
[[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia)
* [http://www.ncbi.nlm.nih.gov/pubmed/16337199 'Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2005''' comparative study, published in [[w:FEBS Letters]]


== Lymphoma and cannabis ==
== Lymphoma and cannabis ==
9,842

edits